Description of Information. 2.4.1 The information covered in this Agreement is as detailed in Section 2.4.2 and where relevant is indicated as personal, sensitive or confidential as defined in Sections 2.2.1, Section 2.2.2 and Section 2.2.3 respectively. The Data Processor shall not disclose information to any third party without the prior written agreement of the Data Controller. Disclosure of such data as may contain patient information will require evidence of Caldicott Guardian approval before disclosure for the purpose of delivery of the contracted service. Other data which may be considered ‘corporate confidential’ or contains information which is sensitive or otherwise person identifiable will require evidence of SIRO and\or Caldicott Guardian approval (as appropriate) before disclosure for the purpose of delivery of the contracted service. In such cases where the signatory to this agreement, acting on behalf of the Data Controller, is not the Caldicott Guardian or SIRO (as appropriate), copies of such approval should be furnished to the aforementioned signatory before he\she signs this document.
Description of Information. Confidential Information includes -------------------------- without limitation (i) information transmitted in written, oral, magnetic or any other medium, and (ii) all copies and reproductions, in whole or in part, of such information and (iii) all summaries, analyses, compilations, studies, notes or other records which contain, reflect, or are generated from such information. Confidential Information does not include information that (w) has become part of the public domain through no act or omission of you; (x) was lawfully disclosed to you without restriction on disclosure by a third party; (y) was developed independently by you; or (z) is or was lawfully and independently provided to you prior to disclosure hereunder, from a third party who is not subject to an obligation of confidentiality or otherwise prohibited from transmitting such information.
Description of Information. Forms of Confidential Information include, without limitation: (a) Confidential Information transmitted in written, oral, magnetic or any other medium; (b) all copies and reproductions, in whole or in part, of Confidential Information; and (c) all summaries, analyses, compilations, studies, notes or other records which contain, reflect, or are generated from Confidential Information. Confidential Information does not include information that: (i) has become part of the public domain through no act or omission of Recipient; (ii) was developed independently by Recipient without reference to Confidential Information (and such independent development can be demonstrated by the Recipient); or (iii) is or was lawfully and independently provided to Recipient, prior to disclosure hereunder, from a third party who, to the knowledge of Recipient, was not subject to an obligation of confidentiality or otherwise prohibited from disclosing or transmitting such information.
Description of Information. The INFORMATION disclosed under this NDA is: information related to the BESC program activities including, but not limited to, research and development objectives, plans, and management plans. INFORMATION includes specific background information, marked in accordance with Paragraph 7 by the Party owning the INFORMATION, in the form of information, data and material related to the foregoing description of INFORMATION which is considered by a Party to be proprietary information or business sensitive privileged commercial and/or financial information. INFORMATION generated from discussions and/or exchanges between or among the Parties pursuant to this NDA shall be identified as confidential, business sensitive, or proprietary at the time of disclosure, orally or visually, and documented and confirmed as such by the Party(ies) who made such disclosure within thirty (30) days of the disclosure. If such INFORMATION is not confirmed and documented in this express manner, no Party to this NDA shall have an obligation of confidentiality with respect to such INFORMATION.
Description of Information. (a) The information to be shared between these organisations under this agreement will consist of: • Details of persons • Details of properties
Description of Information. The INFORMATION disclosed under this NDA is Company’s Proprietary Information related to The Information disclosed under this NDA by UT-Battelle is:
Description of Information. 3.1 The information to be shared by NIHE under this agreement will consist of: Information as to the location, size or description of a dwelling house let under a private tenancy Information as to the name and address of the landlord and tenant of a dwelling house let under a private tenancy or of any person acting as an agent of the landlord
Description of Information. Information Provider will make available the following information under this Agreement (Include the name of the database and a list of all the data elements being provided.): The information described in this section is: Restricted Confidential Information Confidential Information Potentially identifiable information Any reference to information in this Agreement shall be the information as described in this Section.
Description of Information. The parties will make available the following information under thisAgreement: The EHDDI program will provide ESIT with the following data elements for infants who are referred to ESIT through our web-based system. • Primary Contact’s (this will usually be the infant’s parent): o Last Name o First Name o Mailing Address, City, State, Zip Code (OR) o Phone Number (OR) o Email Address • Infant’s Name • Infant’s Date of Birth • Infant’s Gender • Local Lead Agency ID • Referrer’s Name (Audiologist) • Referrer’s Phone Number (Audiologist) • Referrer’s Name (Audiology Clinic) • Referrer’s Phone Number (Audiology Clinic) • Diagnosis • Referral Notes • “Diagnosed condition has a high probability of resulting in a developmental delay.” – Yes/No The ESIT Program will provide the EHDDI Program with the following data elements(when present) for infants who are indicated as having a hearing loss in the ESIT system. • Primary Contact’s Last Name • Primary Contact’s First Name • Infant’s First Name • Infant’s Last Name • Infant’s Date of Birth • Infant’s Gender • Local Lead Agency ID • Referral Date • Referral Source • Diagnosis Type ID(s) • ESIT Eligibility (y/n) • Eligibility Date • Initial IFSP Issue Date • ESIT Service(s) Type • Planned Service(s) Start Date • Actual Service(s) Start Date • Services Not Started Flag, if any • Service(s) Provider Organization • Declined Services (y/n) • Unable to Contact (y/n) The information described in this section is: Restricted Confidential Information Confidential Information (provided by ESIT to the EHDDI Program) Potentially identifiable information (provided by the EHDDI Program to ESIT) Any reference to information in this Agreement shall be the information as described in this Section.
Description of Information. 2.1. The Information disclosed under this NDA is: information of each of the Parties related to the NAWI program activities that a Party considers to be proprietary information or business sensitive, privileged, commercial and/or financial information, including, research and development objectives, plans, and management plans, and may also include specific background information, when such Information is clearly identified and marked as “Confidential” in accordance with Paragraph 8 by the Party owning or having the right to disclose the Information. If such Information is not confirmed and documented in this express manner, no Party to this NDA shall have an obligation of confidentiality with respect to such Information.
